Melanotan-ii typically has a riskier safety profile compared to melanotan-1 due to its non-selective action in the body
Therefore, several clinically approved AEDs are targeting VGSCs, including the widely used phenytoin, lamotrigine, and carbamazepine
Genotype/phenotype relation As new genetic variants related to PFIC were discovered, genotypephenotype relationships emerged [19]
Annual List Review Process Every year, WADA leads the revision process concerning the List, beginning with an initial meeting in January and concluding with the publication of the List by 1 October
However, subclinical deficiency affects between 2.5% and 26% of the general population depending on the definition used, although the clinical relevance is unclear